Technical analysis for TGTX stock forecast shows a golden cross pattern emerging in April 2024, a signal many traders interpret as bullish for the next quarter. RSI remains in neutral territory at The most important thing to take away from this upgrade is that there is now an expectation for TG Therapeutics to become profitable this year, compared to previous expectations of a loss. Pleasantly, analysts also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow slower than the wider market. With a serious upgrade to expectations and a rising price target, it might be time to take another look at TG Therapeutics. $TGTX insiders have traded $TGTX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales. Short-term TGTX stock forecast charts indicate resistance at $23.